IO360° Strategic Advisors

IO360° Founding Advisors
Axel Hoos, M.D., Ph.D.
Former CEO
James Gulley
Co-Director, Center for Immuno-Oncology, CCR & Clinical Director
Industry Advisors
Rick Aldridge
Managing Director,
Michael Kalos
Managing Director
Andrew Baum
Chief Strategy and Innovation Officer
Theresa LaVallee
Chief Development Officer
Jeffrey Bockman
EVP & Expert Advisor, Oncology, Head of Oncology Center of Excellence
David Leung
Head of Imaging
Daniel Chen
Founder & CEO
Jayant Narang
Sr Medical Director, Clinical Oncology Imaging Lead, Preclinical and Translational Sciences
Charles Drake
VP, Immuno-Oncology
Rosanna Ricafort
VP and Head, Hematology and Cellular Therapy Development
Hanif Gabrani-Juma
Associate Director, Translational Medicine Strategy, Radiology Imaging & AI, Oncology R&D Cancer Biomarker Development
Zhen Su
CEO & Director
Diederik Grootendorst
Director, Global Oncology
Graig Suvannavejh
Managing Director, Equity Research Biopharmaceuticals & Biotechnology
Gregory Frank
Global Scientific Partnering Strategy, Immuno-Oncology
Alex Snyder
SVP, Head of Translational Medicine & Discovery Oncology
Greg Goldmacher
Associate VP, Clinical Research, Head, Clinical Imaging & Pathology
Leon Tang
Founder
Asthika Goonewardene
Managing Director, Senior Biotech Analyst
Raluca Verona
Head, Oncology Precision Medicine Group
Priti Hegde
SVP & Global Head of Research
Wim Vos
CEO
Catherine Hines
Executive Director and Head, Clinical Imaging
Sarah Warren
Sr Director, Corporate Development Lead, Cell Therapy Search and Evaluation
William Ho
william.ho@556ventures.com